Related Experiment Video
Updated: May 11, 2026
14:10
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
Wasting mechanisms in muscular dystrophy.
Jonghyun Shin1, Marjan M Tajrishi, Yuji Ogura
1Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Summary
Muscular dystrophy involves progressive muscle wasting due to protein deficiencies. Understanding cellular and molecular mechanisms is key to managing symptoms and improving patient quality of life.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Muscular dystrophy encompasses over 30 genetic disorders causing progressive skeletal muscle wasting.
- Deficiencies in key proteins lead to secondary cellular damage, including necrosis, inflammation, and fibrosis.
- Aberrant signaling pathways exacerbate pathological processes in dystrophic muscles.
Purpose of the Study:
- To review the major cellular and molecular mechanisms underlying muscle wasting in muscular dystrophy.
- To highlight the importance of addressing secondary pathological changes for patient management.
Main Methods:
- Literature review of cellular and molecular mechanisms in muscular dystrophy.
- Analysis of identified molecular processes and signaling pathways involved in disease progression.
Main Results:
- Progressive muscle degeneration is driven by primary protein deficiencies and secondary cellular events.
- Specific molecular pathways significantly hasten disease progression in muscular dystrophy.
- Management of secondary changes offers potential for improved quality of life and lifespan.
Conclusions:
- Addressing secondary pathological changes is crucial for managing muscular dystrophy.
- Further research into cellular and molecular mechanisms can lead to better therapeutic strategies.
- Targeting signaling pathways may mitigate disease progression and improve patient outcomes.
Keywords:
CMDDGCDMDDuchenne muscular dystrophyECMIKKLGMDMAPKMMPsMatrix metalloproteinasesMuRF1Muscular dystrophyNF-kappa BNF-κBNF-κB-inducing kinaseNIKNOOsteopontinRNSROSTGF-βTRPCcongenital muscular dystrophydystrophin glycoprotein complexextracellular matrixinhibitor of I kappa B kinase αlimb-girdle muscular dystrophymatrix metalloproteinasesmitogen-activated protein kinasemuscle RING-finger protein-1nitric oxidenuclear factor-kappa Breactive nitrogen speciesreactive oxygen speciestransforming growth factor-βtransient receptor potential canonical
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:26Cross-bridge Cycle
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:24Muscle Recovery and Fatigue
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...